Max Healthcare
Financials
Estimates*
INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 24.8b | 38.8b | 45.6b | 54.1b | 79.6b | 100.8b | 117.1b |
% growth | 33 % | 56 % | 17 % | 18 % | 47 % | 27 % | 16 % |
EBITDA | 5.5b | 10.7b | 13.8b | 16.7b | 21.7b | 27.5b | 32.1b |
% EBITDA margin | 22 % | 28 % | 30 % | 31 % | 27 % | 27 % | 27 % |
Profit | (1.4b) | 6.1b | 11.0b | 10.6b | 15.0b | 19.8b | 23.1b |
% profit margin | (6 %) | 16 % | 24 % | 20 % | 19 % | 20 % | 20 % |
EV / revenue | 8.2x | 8.8x | 9.2x | 14.8x | 10.4x | 8.1x | 7.2x |
EV / EBITDA | 36.7x | 31.8x | 30.5x | 47.9x | 38.3x | 29.6x | 26.1x |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
N/A | $164m | Private Placement VC | |
* | $50.1m | Post IPO Equity | |
Total Funding | €149m |
Recent News about Max Healthcare
EditMax Healthcare operates as one of India's premier healthcare service providers, delivering comprehensive medical care through a network of 14 hospitals. The company serves a diverse clientele, including local and international patients, offering treatments across 29 specialties such as oncology, cardiology, orthopedics, and liver transplants. Max Healthcare's business model revolves around providing high-quality medical services, leveraging advanced technologies like the Da Vinci Xi robotic surgery system. The company generates revenue through patient fees, specialized treatments, and surgical procedures. With a strong focus on innovation and patient care, Max Healthcare has achieved significant financial growth, reporting a revenue of INR 1,434 Cr and an operating EBITDA of INR 362 Cr. The company continues to expand its services and technological capabilities to maintain its position as a trusted healthcare provider in India.
Keywords: healthcare, hospitals, specialties, oncology, cardiology, orthopedics, liver transplants, robotic surgery, patient care, innovation.